Tag: Diabetes: Type I
Vitamin D Supplementation May Aid New-Onset Pediatric T1DM
A serum 25(OH)D target of 30 to 60 ng/mL is safe, effective, and recommended for children and adolescents with type 1 diabetes
Multidose BCG Protects Against COVID-19 in At-Risk Individuals
Efficacy of 92 percent found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes
SARS-CoV-2 Infection Not Linked to T1DM-Related Autoimmunity
No significant association seen with presence of multiple islet autoantibodies, single high-affinity islet autoantibodies in children, teens
Daily Insulin Dose Tied to Cancer Risk in Patients With T1DM
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups
ENDO: Disparities Seen in Access to Insulin Pumps for Youth With T1D
Likelihood of insulin pump use for T1D increased for Hispanic youth, but not for youth of Black and other races compared to non-Hispanic Whites
Older Adults With Type 1 Diabetes Have Lower Grip Strength
Additionally, lower diastolic blood pressure seen with type 1 diabetes versus matched controls
ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
Open-source automated insulin delivery compared to sensor augmented pump therapy in adults and children with T1D
ADA: Elevated BMI in Adolescence Linked to T1D in Young Adulthood
Risk for incidence of type 1 diabetes increased 25 percent in association with one increment in BMI standard deviation
Outcomes Worse for Children With Type 1 Diabetes Who Are Black
Disparities in T1D outcomes seen for Black children compared with Hispanic, White children from neighborhoods with similar opportunity levels
Childhood Body Size Has Causal Impact on T1D Risk
Direct effect of body size validated using data from meta-analysis including 15,573 cases and 158,408 controls
